Evidence map›Paper›PMID 40397077›Full record

ArticleBioinformatics (Oxford, England)2025

esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.

Jiaqi Li, Pengcheng Zhang, Xi Xi, Xiaowo Wang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiaqi LiMinistry of Education Key Laboratory of Bioinformatics; Center for Synthetic and Systems Biology; Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing 100084, China.ORCID 0000-0001-9038-9010
Pengcheng ZhangMinistry of Education Key Laboratory of Bioinformatics; Center for Synthetic and Systems Biology; Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing 100084, China.ORCID 0000-0003-3524-3478
Xi XiMinistry of Education Key Laboratory of Bioinformatics; Center for Synthetic and Systems Biology; Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing 100084, China.
Xiaowo WangMinistry of Education Key Laboratory of Bioinformatics; Center for Synthetic and Systems Biology; Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing 100084, China.ORCID 0000-0003-2965-8036

Funding

National Key R&D Program of China 2023YFF1204500National Natural Science Foundation of China 62225307
6 · The paper itself

Abstract

motivationMassively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus robust and user-friendly quality control methods are essential to minimize experimental failures and ensure reproducibility between replicates.

resultsHere, we present esMPRA, an integrated quality control and analysis pipeline designed for MPRA experiments. Building on our experience in MPRA and its derivative techniques, coupled with systematic analysis of public MPRA datasets, we established standardized quality control metrics and developed a stepwise quality monitoring framework. esMPRA generates stage-specific diagnostic reports and provides experimental recommendations to avoid potential risks throughout the workflow. Designed for maximal accessibility, esMPRA features a one-line command-line interface and requires minimal bioinformatics expertise. Beyond quality assessment, the pipeline delivers processed data outputs, comprehensive analysis reports, and interface files compatible with downstream analyses, establishing an end-to-end solution for MPRA experimentation. AVAILABILITY AND IMPLEMENTATION: esMPRA is released as an open-source software under the MIT license. The source code for esMPRA is available on Zenodo (DOI: 10.5281/zenodo.15362711) and GitHub (https://github.com/WangLabTHU/esMPRA/) for Linux, macOS, and Windows and is available via PyPI as esMPRA. Data for testing and reference is available via Zenodo repository at https://zenodo.org/records/15034449.

Indexed as

Computational BiologyHigh-Throughput Nucleotide SequencingSoftwareData AnalysisHumansQuality Control

Identifiers

PMID40397077
PMCPMC12133320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.